{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:57:32Z","timestamp":1791388652627,"version":"4.3.3"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"DOI":"10.1007\/s43032-026-02220-6","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:41:06Z","timestamp":1791387666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Gut-Insulin Axis in Polycystic Ovary Syndrome: A Narrative Review of Gut Dysbiosis, Inflammation, and Emerging Therapeutic Strategies"],"prefix":"10.1007","author":[{"family":"Shruti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"1","key":"2220_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12978-025-02016-y","volume":"22","author":"T Lin","year":"2025","unstructured":"Lin T, Xie B, Yang J, Xu J, Chen F. Changes in the global burden of polycystic ovary syndrome from 1990 to 2021. Reprod Health. 2025;22(1):86. https:\/\/doi.org\/10.1186\/s12978-025-02016-y.","journal-title":"Reprod Health"},{"key":"2220_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/IJWH.S490836","volume":"17","author":"B Jiang","year":"2025","unstructured":"Jiang B. The global burden of polycystic ovary syndrome in women of reproductive age: findings from the GBD 2019 study. Int J Womens Health. 2025;17:153\u201365. https:\/\/doi.org\/10.2147\/IJWH.S490836.","journal-title":"Int J Womens Health"},{"issue":"3","key":"2220_CR3","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021;106(3):e1071\u201383. https:\/\/doi.org\/10.1210\/clinem\/dgaa839.","journal-title":"J Clin Endocrinol Metab"},{"key":"2220_CR4","doi-asserted-by":"publisher","first-page":"1569694","DOI":"10.3389\/fendo.2025.1569694","volume":"16","author":"J Wang","year":"2025","unstructured":"Wang J, et al. Evolving global trends in PCOS burden: a three-decade analysis (1990\u20132021) with projections to 2036 among adolescents and young adults. Front Endocrinol. 2025;16:1569694. https:\/\/doi.org\/10.3389\/fendo.2025.1569694.","journal-title":"Front Endocrinol"},{"issue":"4","key":"2220_CR5","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/jcm12041500","volume":"12","author":"Y Che","year":"2023","unstructured":"Che Y, Yu J, Li Y-S, Zhu Y-C, Tao T. Polycystic ovary syndrome: challenges and possible solutions. J Clin Med. 2023;12(4):1500. https:\/\/doi.org\/10.3390\/jcm12041500.","journal-title":"J Clin Med"},{"key":"2220_CR6","doi-asserted-by":"publisher","unstructured":"Holton S, Hammarberg K, Johnson L. Fertility concerns and related information needs and preferences of women with PCOS. Hum Reprod Open. 2018;2018(4). https:\/\/doi.org\/10.1093\/hropen\/hoy019.","DOI":"10.1093\/hropen\/hoy019"},{"issue":"3","key":"2220_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00404-024-07916-1","volume":"311","author":"A Bachmann","year":"2025","unstructured":"Bachmann A, et al. Unmet clinical needs in women with polycystic ovary syndrome regarding fertility and obesity: a cross-sectional study from the patient\u2019s perspective. Arch Gynecol Obstet. 2025;311(3):851\u20139. https:\/\/doi.org\/10.1007\/s00404-024-07916-1.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2220_CR8","doi-asserted-by":"publisher","first-page":"2357737","DOI":"10.1080\/07853890.2024.2357737","volume":"56","author":"NA Sta\u0144czak","year":"2024","unstructured":"Sta\u0144czak NA, Grywalska E, Dudzi\u0144ska E. The latest reports and treatment methods on polycystic ovary syndrome. Ann Med. 2024;56(1):2357737. https:\/\/doi.org\/10.1080\/07853890.2024.2357737.","journal-title":"Ann Med"},{"issue":"1","key":"2220_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16(1):9. https:\/\/doi.org\/10.1186\/s13048-022-01091-0.","journal-title":"J Ovarian Res"},{"key":"2220_CR10","doi-asserted-by":"publisher","first-page":"1508893","DOI":"10.3389\/fcimb.2025.1508893","volume":"15","author":"Y Mei","year":"2025","unstructured":"Mei Y, et al. Gut microbiota: an emerging target connecting polycystic ovarian syndrome and insulin resistance. Front Cell Infect Microbiol. 2025;15:1508893. https:\/\/doi.org\/10.3389\/fcimb.2025.1508893.","journal-title":"Front Cell Infect Microbiol"},{"issue":"50","key":"2220_CR11","doi-asserted-by":"publisher","first-page":"e36075","DOI":"10.1097\/MD.0000000000036075","volume":"102","author":"H Guo","year":"2023","unstructured":"Guo H, Luo J, Lin H. Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: a review. Med (Baltim). 2023;102(50):e36075. https:\/\/doi.org\/10.1097\/MD.0000000000036075.","journal-title":"Med (Baltim)"},{"key":"2220_CR12","doi-asserted-by":"publisher","unstructured":"Li L, et al. Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome. Int J Mol Med. 2020. https:\/\/doi.org\/10.3892\/ijmm.2020.4522.","DOI":"10.3892\/ijmm.2020.4522"},{"issue":"1","key":"2220_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.resmic.2018.09.002","volume":"170","author":"B Zeng","year":"2019","unstructured":"Zeng B, et al. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study. Res Microbiol. 2019;170(1):43\u201352. https:\/\/doi.org\/10.1016\/j.resmic.2018.09.002.","journal-title":"Res Microbiol"},{"issue":"4","key":"2220_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","volume":"26","author":"RS Kootte","year":"2017","unstructured":"Kootte RS, et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 2017;26(4):611\u20139. https:\/\/doi.org\/10.1016\/j.cmet.2017.09.008.","journal-title":"Cell Metab"},{"key":"2220_CR15","doi-asserted-by":"publisher","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1). https:\/\/doi.org\/10.1186\/s41073-019-0064-8.","DOI":"10.1186\/s41073-019-0064-8"},{"issue":"6","key":"2220_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.31083\/j.ceog5106142","volume":"51","author":"A Elnashar","year":"2024","unstructured":"Elnashar A. Lean polycystic ovary syndrome: a narrative review. Clin Exp Obstet Gynecol. 2024;51(6):142. https:\/\/doi.org\/10.31083\/j.ceog5106142.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"5","key":"2220_CR17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/cen.13808","volume":"89","author":"S Shorakae","year":"2018","unstructured":"Shorakae S, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol (Oxf). 2018;89(5):628\u201333. https:\/\/doi.org\/10.1111\/cen.13808","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2220_CR18","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22:3789. https:\/\/doi.org\/10.3390\/ijms22073789.","journal-title":"Int J Mol Sci"},{"key":"2220_CR19","doi-asserted-by":"publisher","first-page":"741764","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, et al. Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol. 2021;12:741764. https:\/\/doi.org\/10.3389\/fendo.2021.741764.","journal-title":"Front Endocrinol"},{"key":"2220_CR20","doi-asserted-by":"publisher","first-page":"1549499","DOI":"10.3389\/fmicb.2025.1549499","volume":"16","author":"A Hanna","year":"2025","unstructured":"Hanna A, Abbas H, Yassine F, AlBush A, Bilen M. Systematic review of gut microbiota composition, metabolic alterations, and the effects of treatments on PCOS and gut microbiota across human and animal studies. Front Microbiol. 2025;16:1549499. https:\/\/doi.org\/10.3389\/fmicb.2025.1549499.","journal-title":"Front Microbiol"},{"issue":"4","key":"2220_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/sci6040075","volume":"6","author":"CI Aquino","year":"2024","unstructured":"Aquino CI, Nicosia A, Ligori A, Volpicelli AI, Surico D. Microbiota status and endometrial cancer: a narrative review about possible correlations in affected versus healthy patients. Sci. 2024;6(4):75. https:\/\/doi.org\/10.3390\/sci6040075.","journal-title":"Sci"},{"key":"2220_CR22","doi-asserted-by":"publisher","first-page":"1529703","DOI":"10.3389\/fendo.2025.1529703","volume":"16","author":"C Li","year":"2025","unstructured":"Li C, Cheng D, Ren H, Zhang T. Unraveling the gut microbiota\u2019s role in PCOS: a new frontier in metabolic health. Front Endocrinol. 2025;16:1529703. https:\/\/doi.org\/10.3389\/fendo.2025.1529703.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2220_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-020-01244-4","volume":"19","author":"E Karimi","year":"2020","unstructured":"Karimi E, et al. The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial. Lipids Health Dis. 2020;19(1):60. https:\/\/doi.org\/10.1186\/s12944-020-01244-4.","journal-title":"Lipids Health Dis"},{"key":"2220_CR24","doi-asserted-by":"publisher","first-page":"1526468","DOI":"10.3389\/fendo.2025.1526468","volume":"16","author":"J Li","year":"2025","unstructured":"Li J, et al. Metabolic disorders in polycystic ovary syndrome: from gut microbiota biodiversity to clinical intervention. Front Endocrinol. 2025;16:1526468. https:\/\/doi.org\/10.3389\/fendo.2025.1526468.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2220_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13048-020-00670-3","volume":"13","author":"F He","year":"2020","unstructured":"He F, Li Y. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020;13(1):73. https:\/\/doi.org\/10.1186\/s13048-020-00670-3.","journal-title":"J Ovarian Res"},{"key":"2220_CR26","doi-asserted-by":"publisher","first-page":"102884","DOI":"10.1016\/j.eclinm.2024.102884","volume":"77","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. Gut microbiota in women with polycystic ovary syndrome: an individual based analysis of publicly available data. eClinicalMedicine. 2024;77:102884. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102884.","journal-title":"eClinicalMedicine"},{"issue":"1","key":"2220_CR27","doi-asserted-by":"publisher","first-page":"29848","DOI":"10.1038\/s41598-024-81034-5","volume":"14","author":"Q Yang","year":"2024","unstructured":"Yang Q, Wan Q, Wang Z. Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4\/MyD88\/NF-\u03baB signaling pathway activation and reducing intestinal mucosal permeability. Sci Rep. 2024;14(1):29848. https:\/\/doi.org\/10.1038\/s41598-024-81034-5.","journal-title":"Sci Rep"},{"issue":"6","key":"2220_CR28","doi-asserted-by":"publisher","first-page":"e250162","DOI":"10.1530\/EC-25-0162","volume":"14","author":"X Huang","year":"2025","unstructured":"Huang X, Wu L, Zhang Y, Lai X, Sun D. The role of microbiota and toll-like receptors in polycystic ovary syndrome: regulatory mechanisms of androgen metabolism. Endocr Connect. 2025;14(6):e250162. https:\/\/doi.org\/10.1530\/EC-25-0162.","journal-title":"Endocr Connect"},{"issue":"6","key":"2220_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/cimb47060424","volume":"47","author":"S Borozan","year":"2025","unstructured":"Borozan S, Fernandez CJ, Samee A, Pappachan JM. Gut\u2013adipose tissue axis and metabolic health. Curr Issues Mol Biol. 2025;47(6):424. https:\/\/doi.org\/10.3390\/cimb47060424.","journal-title":"Curr Issues Mol Biol"},{"issue":"6418","key":"2220_CR30","doi-asserted-by":"publisher","first-page":"eaat9076","DOI":"10.1126\/science.aat9076","volume":"362","author":"Y Litvak","year":"2018","unstructured":"Litvak Y, Byndloss MX, B\u00e4umler AJ. Colonocyte metabolism shapes the gut microbiota. Science. 2018;362(6418):eaat9076. https:\/\/doi.org\/10.1126\/science.aat9076.","journal-title":"Science"},{"issue":"6","key":"2220_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341\u201352. https:\/\/doi.org\/10.1038\/nri.2016.42.","journal-title":"Nat Rev Immunol"},{"key":"2220_CR32","doi-asserted-by":"publisher","first-page":"747888","DOI":"10.3389\/fendo.2021.747888","volume":"12","author":"W Lin","year":"2021","unstructured":"Lin W, Wen L, Wen J, Xiang G. Effects of sleeve gastrectomy on fecal gut microbiota and short-chain fatty acid content in a rat model of polycystic ovary syndrome. Front Endocrinol. 2021;12:747888. https:\/\/doi.org\/10.3389\/fendo.2021.747888.","journal-title":"Front Endocrinol"},{"issue":"6","key":"2220_CR33","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A De Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell Jun. 2016;165(6):1332\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.05.041.","journal-title":"Cell Jun"},{"key":"2220_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jsbmb.2016.07.005","volume":"170","author":"CC Au","year":"2017","unstructured":"Au CC, et al. Des-acyl ghrelin inhibits the capacity of macrophages to stimulate the expression of aromatase in breast adipose stromal cells. J Steroid Biochem Mol Biol. 2017;170:49\u201353. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.07.005.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2220_CR35","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1038\/srep04855","volume":"4","author":"MG Novelle","year":"2014","unstructured":"Novelle MG, V\u00e1zquez MJ, Martinello KD, Sanchez-Garrido MA, Tena-Sempere M, Di\u00e9guez C. Neonatal events, such as androgenization and postnatal overfeeding, modify the response to ghrelin. Sci Rep. 2014;4(1):4855. https:\/\/doi.org\/10.1038\/srep04855.","journal-title":"Sci Rep"},{"issue":"1","key":"2220_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1507\/endocrj.EJ15-0318","volume":"63","author":"T Gao","year":"2016","unstructured":"Gao T, Wu L, Chang F, Cao G. Low circulating ghrelin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocr J. 2016;63(1):93\u2013100. https:\/\/doi.org\/10.1507\/endocrj.EJ15-0318.","journal-title":"Endocr J"},{"issue":"1","key":"2220_CR37","doi-asserted-by":"publisher","first-page":"e0146509","DOI":"10.1371\/journal.pone.0146509","volume":"11","author":"ST Kelley","year":"2016","unstructured":"Kelley ST, Skarra DV, Rivera AJ, Thackray VG. The gut microbiome is altered in a Letrozole-induced mouse model of polycystic ovary syndrome. PLoS ONE. 2016;11(1):e0146509. https:\/\/doi.org\/10.1371\/journal.pone.0146509.","journal-title":"PLoS ONE"},{"issue":"02","key":"2220_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/a-1081-2036","volume":"80","author":"X Zhao","year":"2020","unstructured":"Zhao X, Jiang Y, Xi H, Chen L, Feng X. Exploration of the relationship between gut microbiota and polycystic ovary syndrome (PCOS): a review. Geburtshilfe Frauenheilkd. 2020;80(02):161\u201371. https:\/\/doi.org\/10.1055\/a-1081-2036.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2220_CR39","doi-asserted-by":"publisher","first-page":"933110","DOI":"10.3389\/fendo.2022.933110","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, et al. Present and future: crosstalks between polycystic ovary syndrome and gut metabolites relating to gut microbiota. Front Endocrinol. 2022;13:933110. https:\/\/doi.org\/10.3389\/fendo.2022.933110.","journal-title":"Front Endocrinol"},{"issue":"4","key":"2220_CR40","doi-asserted-by":"publisher","first-page":"bqaa018","DOI":"10.1210\/endocr\/bqaa018","volume":"161","author":"LA Esparza","year":"2020","unstructured":"Esparza LA, Schafer D, Ho BS, Thackray VG, Kauffman AS. Hyperactive LH pulses and elevated kisspeptin and NKB gene expression in the arcuate nucleus of a PCOS mouse model. Endocrinology. 2020;161(4):bqaa018. https:\/\/doi.org\/10.1210\/endocr\/bqaa018.","journal-title":"Endocrinology"},{"issue":"4","key":"2220_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.xfre.2023.08.009","volume":"4","author":"KI Sarkisian","year":"2023","unstructured":"Sarkisian KI, Ho L, Yang J, Mandelbaum R, Stanczyk FZ. Neuroendocrine, neurotransmitter, and gut microbiota imbalance contributing to potential psychiatric disorder prevalence in polycystic ovarian syndrome. FS Rep. 2023;4(4):337\u201342. https:\/\/doi.org\/10.1016\/j.xfre.2023.08.009.","journal-title":"FS Rep"},{"key":"2220_CR42","doi-asserted-by":"publisher","first-page":"877807","DOI":"10.3389\/fendo.2022.877807","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, et al. Abnormal activation of tryptophan-kynurenine pathway in women with polycystic ovary syndrome. Front Endocrinol. 2022;13:877807. https:\/\/doi.org\/10.3389\/fendo.2022.877807.","journal-title":"Front Endocrinol"},{"issue":"5","key":"2220_CR43","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1021\/acs.jproteome.4c00937","volume":"24","author":"A Gkantzos","year":"2025","unstructured":"Gkantzos A, Kalogiannis S, Deda O. The role of aromatic amino acids in polycystic ovary syndrome through patients\u2019 blood metabolic profiling: a systematic review of the past five years. J Proteome Res. 2025;24(5):2208\u201321. https:\/\/doi.org\/10.1021\/acs.jproteome.4c00937.","journal-title":"J Proteome Res"},{"issue":"3","key":"2220_CR44","doi-asserted-by":"publisher","first-page":"102663","DOI":"10.1016\/j.omtn.2025.102663","volume":"36","author":"S Qian","year":"2025","unstructured":"Qian S, Pan G, Fan M. FOXO4-AR crosstalk in PCOS: A pivotal mechanism of anovulation. Mol Ther Nucleic Acids. 2025;36(3):102663. https:\/\/doi.org\/10.1016\/j.omtn.2025.102663.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2220_CR45","doi-asserted-by":"publisher","first-page":"1470283","DOI":"10.3389\/fimmu.2024.1470283","volume":"15","author":"H Deng","year":"2024","unstructured":"Deng H, Chen Y, Xing J, Zhang N, Xu L. Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome. Front Immunol. 2024;15:1470283. https:\/\/doi.org\/10.3389\/fimmu.2024.1470283.","journal-title":"Front Immunol"},{"issue":"4","key":"2220_CR46","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","volume":"10","author":"CS Plottel","year":"2011","unstructured":"Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe. 2011;10(4):324\u201335. https:\/\/doi.org\/10.1016\/j.chom.2011.10.003.","journal-title":"Cell Host Microbe"},{"key":"2220_CR47","doi-asserted-by":"publisher","first-page":"1747766","DOI":"10.3389\/fendo.2026.1747766","volume":"17","author":"X Du","year":"2026","unstructured":"Du X, et al. Gut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies. Front Endocrinol. 2026;17:1747766. https:\/\/doi.org\/10.3389\/fendo.2026.1747766.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2220_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13048-026-02081-2","volume":"19","author":"J Patel","year":"2026","unstructured":"Patel J, Chaudhary H, Parekh B, Joshi R. Exploring gut microbiome alterations and hormonal imbalances in polycystic ovary syndrome: insights from a comparative study. J Ovarian Res. 2026;19(1):185. https:\/\/doi.org\/10.1186\/s13048-026-02081-2.","journal-title":"J Ovarian Res"},{"key":"2220_CR49","unstructured":"Manos A. The estrobolome: the gut microbiome-estrogen connection. Healthpath. Available: https:\/\/healthpath.com\/gut-health\/the-estrobolome-the-gut-microbiome-estrogen-connection\/.\u00a0 Accessed Aug. 09, 2026."},{"key":"2220_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","volume":"103","author":"JM Baker","year":"2017","unstructured":"Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen\u2013gut microbiome axis: physiological and clinical implications. Maturitas. 2017;103:45\u201353. https:\/\/doi.org\/10.1016\/j.maturitas.2017.06.025.","journal-title":"Maturitas"},{"key":"2220_CR51","doi-asserted-by":"publisher","unstructured":"Kwa M et al. The intestinal microbiome and estrogen receptor\u2013positive female breast cancer. JNCI J Natl Cancer Inst. 2016. https:\/\/doi.org\/10.1093\/jnci\/djw029.","DOI":"10.1093\/jnci\/djw029"},{"issue":"1","key":"2220_CR52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12866-024-03513-z","volume":"24","author":"F Huang","year":"2024","unstructured":"Huang F, Deng Y, Zhou M, Tang R, Zhang P, Chen R. Fecal microbiota transplantation from patients with polycystic ovary syndrome induces metabolic disorders and ovarian dysfunction in germ-free mice. BMC Microbiol. 2024;24(1):364. https:\/\/doi.org\/10.1186\/s12866-024-03513-z.","journal-title":"BMC Microbiol"},{"issue":"6","key":"2220_CR53","doi-asserted-by":"publisher","first-page":"208","DOI":"10.31083\/j.fbl2906208","volume":"29","author":"Y Li","year":"2024","unstructured":"Li Y, Fang Y, Wang H, Zhang H. Balancing act: exploring the gut microbiota-brown adipose tissue axis in PCOS pathogenesis and therapeutic frontiers. Front Biosci 2024;29(6):208. https:\/\/doi.org\/10.31083\/j.fbl2906208.","journal-title":"Front Biosci -Landmark"},{"key":"2220_CR54","doi-asserted-by":"publisher","first-page":"2412558","DOI":"10.1002\/advs.202412558","volume":"12","author":"L Geng","year":"2025","unstructured":"Geng L, et al. Gut microbiota modulation by inulin improves metabolism and ovarian function in polycystic ovary syndrome. Adv Sci. 2025;12:2412558. https:\/\/doi.org\/10.1002\/advs.202412558.","journal-title":"Adv Sci"},{"issue":"1","key":"2220_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s13668-024-00601-4","volume":"14","author":"C Johnson","year":"2025","unstructured":"Johnson C, Garipo\u011flu G, Jeanes Y, Frontino G, Costabile A. The role of diet, glycaemic index and glucose control in polycystic ovary syndrome (PCOS) management and mechanisms of progression. Curr Nutr Rep. 2025;14(1):8. https:\/\/doi.org\/10.1007\/s13668-024-00601-4.","journal-title":"Curr Nutr Rep"},{"issue":"2","key":"2220_CR56","doi-asserted-by":"publisher","first-page":"559","DOI":"10.12944\/CRNFSJ.13.2.2","volume":"13","author":"N Krishnan","year":"2025","unstructured":"Krishnan N, Narayanan P, Venkatachalam DP, Velraja S. Role of diet and gut microbiome composition in women with polycystic ovarian syndrome (PCOS): a systematic review. Curr Res Nutr Food Sci J. 2025;13(2):559\u201368. https:\/\/doi.org\/10.12944\/CRNFSJ.13.2.2.","journal-title":"Curr Res Nutr Food Sci J"},{"issue":"3","key":"2220_CR57","doi-asserted-by":"publisher","first-page":"251","DOI":"10.21101\/cejph.a5313","volume":"27","author":"E Hijov\u00e1","year":"2019","unstructured":"Hijov\u00e1 E, Bertkov\u00e1 I, \u0160tofilov\u00e1 J. Dietary fibre as prebiotics in nutrition. Cent Eur J Public Health. 2019;27(3):251\u20135. https:\/\/doi.org\/10.21101\/cejph.a5313.","journal-title":"Cent Eur J Public Health"},{"issue":"10","key":"2220_CR58","first-page":"1239","volume":"5","author":"S Mahboobi","year":"2014","unstructured":"Mahboobi S, et al. The effects of probiotic supplementation on markers of blood lipids, and blood pressure in patients with prediabetes: a randomized clinical trial. Int J Prev Med. 2014;5(10):1239\u201346.","journal-title":"Int J Prev Med"},{"issue":"2","key":"2220_CR59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00394-019-02033-1","volume":"59","author":"SG Shamasbi","year":"2020","unstructured":"Shamasbi SG, Ghanbari-Homayi S, Mirghafourvand M. The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Nutr. 2020;59(2):433\u201350. https:\/\/doi.org\/10.1007\/s00394-019-02033-1.","journal-title":"Eur J Nutr"},{"issue":"12","key":"2220_CR60","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","volume":"52","author":"KR Pandey","year":"2015","unstructured":"Pandey KR, Naik SR, Vakil BV. Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol. 2015;52(12):7577\u201387. https:\/\/doi.org\/10.1007\/s13197-015-1921-1.","journal-title":"J Food Sci Technol"},{"issue":"1","key":"2220_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5468\/ogs.21185","volume":"65","author":"J Parker","year":"2022","unstructured":"Parker J, O\u2019Brien C, Hawrelak J. A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome. Obstet Gynecol Sci. 2022;65(1):14\u201328. https:\/\/doi.org\/10.5468\/ogs.21185.","journal-title":"Obstet Gynecol Sci"},{"issue":"4","key":"2220_CR62","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s12602-018-9405-z","volume":"11","author":"M Samimi","year":"2019","unstructured":"Samimi M, Dadkhah A, Haddad Kashani H, Tajabadi-Ebrahimi M, Seyed Hosseini E, Asemi Z. The effects of synbiotic supplementation on metabolic status in women with polycystic ovary syndrome: a randomized double-blind clinical trial. Probiotics Antimicrob Proteins. 2019;11(4):1355\u201361. https:\/\/doi.org\/10.1007\/s12602-018-9405-z.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"2220_CR63","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13048-018-0457-1","volume":"11","author":"M Jamilian","year":"2018","unstructured":"Jamilian M, Mansury S, Bahmani F, Heidar Z, Amirani E, Asemi Z. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. J Ovarian Res. 2018;11(1):80. https:\/\/doi.org\/10.1186\/s13048-018-0457-1.","journal-title":"J Ovarian Res"},{"issue":"1","key":"2220_CR64","first-page":"1","volume":"21","author":"M Karamali","year":"2018","unstructured":"Karamali M, et al. Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Arch Iran Med. 2018;21(1):1\u20137.","journal-title":"Arch Iran Med"},{"issue":"2","key":"2220_CR65","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00394-018-1648-7","volume":"58","author":"S Gholizadeh Shamasbi","year":"2019","unstructured":"Gholizadeh Shamasbi S, Dehgan P, Mohammad-Alizadeh Charandabi S, Aliasgarzadeh A, Mirghafourvand M. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Eur J Nutr. 2019;58(2):629\u201340. https:\/\/doi.org\/10.1007\/s00394-018-1648-7.","journal-title":"Eur J Nutr"},{"issue":"2","key":"2220_CR66","doi-asserted-by":"publisher","first-page":"pp. e00017-19","DOI":"10.1128\/mSystems.00017-19","volume":"4","author":"J Zhang","year":"2019","unstructured":"Zhang J et al. Probiotic Bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis. mSystems. 2019;4(2):pp. e00017-19. https:\/\/doi.org\/10.1128\/mSystems.00017-19.","journal-title":"mSystems"},{"key":"2220_CR67","doi-asserted-by":"publisher","unstructured":"Darvishi S, Rafraf M, Jafarabadi MA, Farzadi L. Synbiotic supplementation improves metabolic factors and obesity values in women with polycystic ovary syndrome independent of affecting apelin levels: a randomized double-blind placebo-controlled clinical trial. Int J Fertil Steril. 2021;15(1). https:\/\/doi.org\/10.22074\/ijfs.2021.6186.","DOI":"10.22074\/ijfs.2021.6186"},{"issue":"8","key":"2220_CR68","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1007\/s00394-022-02959-z","volume":"61","author":"I Kaur","year":"2022","unstructured":"Kaur I, et al. Efficacy of multi-strain probiotic along with dietary and lifestyle modifications on polycystic ovary syndrome: a randomised, double-blind placebo-controlled study. Eur J Nutr. 2022;61(8):4145\u201354. https:\/\/doi.org\/10.1007\/s00394-022-02959-z.","journal-title":"Eur J Nutr"},{"issue":"1","key":"2220_CR69","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1186\/s13063-023-07691-5","volume":"24","author":"S Talebi","year":"2023","unstructured":"Talebi S, Shab-Bidar S, Mohammadi H, Moini A, Djafarian K. The effects of intermittent fasting diet alone or in combination with probiotic supplementation in comparison with calorie-restricted diet on metabolic and hormonal profile in patients with polycystic ovary syndrome: study protocol for a randomized clinical trial. Trials. 2023;24(1):690. https:\/\/doi.org\/10.1186\/s13063-023-07691-5.","journal-title":"Trials"},{"key":"2220_CR70","doi-asserted-by":"publisher","first-page":"1141355","DOI":"10.3389\/fmed.2023.1141355","volume":"10","author":"P Angoorani","year":"2023","unstructured":"Angoorani P, et al. The effects of probiotics, prebiotics, and synbiotics on polycystic ovarian syndrome: an overview of systematic reviews. Front Med. 2023;10:1141355. https:\/\/doi.org\/10.3389\/fmed.2023.1141355.","journal-title":"Front Med"},{"issue":"8","key":"2220_CR71","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/aps.2016.21","volume":"37","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Ren L, Zhan P, Yang H, Chai D, Yu Z. Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling. Acta Pharmacol Sin. 2016;37(8):1063\u201375. https:\/\/doi.org\/10.1038\/aps.2016.21.","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"2220_CR72","doi-asserted-by":"publisher","first-page":"932","DOI":"10.4239\/wjd.v12.i7.932","volume":"12","author":"J Marinkovic-Radosevic","year":"2021","unstructured":"Marinkovic-Radosevic J, Cigrovski Berkovic M, Kruezi E, Bilic-Curcic I, Mrzljak A. Exploring new treatment options for polycystic ovary syndrome: review of a novel antidiabetic agent SGLT2 inhibitor. World J Diabetes. 2021;12(7):932\u20138. https:\/\/doi.org\/10.4239\/wjd.v12.i7.932.","journal-title":"World J Diabetes"},{"issue":"6","key":"2220_CR73","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/cen.13968","volume":"90","author":"Z Javed","year":"2019","unstructured":"Javed Z, et al. Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study. Clin Endocrinol (Oxf). 2019;90(6):805\u201313. https:\/\/doi.org\/10.1111\/cen.13968.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2220_CR74","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12967-025-06315-7","volume":"23","author":"H Senthilkumar","year":"2025","unstructured":"Senthilkumar H, Arumugam M. Gut microbiota: a hidden player in polycystic ovary syndrome. J Transl Med. 2025;23(1):443. https:\/\/doi.org\/10.1186\/s12967-025-06315-7.","journal-title":"J Transl Med"},{"issue":"6","key":"2220_CR75","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/biom15060834","volume":"15","author":"B Kushawaha","year":"2025","unstructured":"Kushawaha B, Rem TT, Pelosi E. Harnessing microbiome, bacterial extracellular vesicle, and artificial intelligence for polycystic ovary syndrome diagnosis and management. Biomolecules. 2025;15(6):834. https:\/\/doi.org\/10.3390\/biom15060834.","journal-title":"Biomolecules"},{"issue":"14","key":"2220_CR76","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.3390\/nu15143144","volume":"15","author":"V Calcaterra","year":"2023","unstructured":"Calcaterra V, Rossi V, Massini G, Casini F, Zuccotti G, Fabiano V. Probiotics and polycystic ovary syndrome: a perspective for management in adolescents with obesity. Nutrients. 2023;15(14):3144. https:\/\/doi.org\/10.3390\/nu15143144.","journal-title":"Nutrients"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02220-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02220-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02220-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:41:09Z","timestamp":1791387669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-026-02220-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":76,"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02220-6","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript is a review article that utilizes data from previously published studies. No new human or animal subjects were involved. Accordingly, institutional review board (IRB) approval is not required.","order":1,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author consents to the publication of this manuscript.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest or competing interests.","order":3,"name":"Ethics","label":"Conflicts of Interest\/Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}